Literature DB >> 8988298

Early primary valve ablation for posterior urethral valves.

M E Mitchell1, C E Close.   

Abstract

Early diagnosis and the use of new pediatric endoscopic equipment have significantly improved the survival of infant boys with posterior urethral valves. The sequelae of urethral obstruction in these patients includes abnormalities in the urethra, bladder, ureters, and kidneys. The question remains of how best to treat all valve patients to maximize function of the entire urinary tract. Our experience with early valve ablation (EVA) suggests that the damaged bladder and upper tracts have a potential to heal if the obstruction is removed and the bladder is allowed to fill and empty cyclically in the first few months of life. One year after EVA, even patients with severe obstructive changes show return of normal bladder capacity and compliance, and resolution or improvement in reflux. Unfortunately, the renal insufficiency associated with valves often is secondary to primary renal dysplasia, with many patients progressing to renal failure and transplantation. Upper tract diversion has failed to improve long-term outcome in patients with renal dysplasia; furthermore, it jeopardizes the potential for bladder healing and normal bladder function. Therefore, even for patients with renal insufficiency, early primary ablation should be used as the definitive treatment for posterior urethral valves.

Entities:  

Mesh:

Year:  1996        PMID: 8988298

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  4 in total

1.  Mechanotransduction of extracellular signal-regulated kinases 1 and 2 mitogen-activated protein kinase activity in smooth muscle is dependent on the extracellular matrix and regulated by matrix metalloproteinases.

Authors:  Karen J Aitken; Gregory Block; Armando Lorenzo; Daniel Herz; Nesrin Sabha; Omar Dessouki; France Fung; Marta Szybowska; Laura Craig; Darius J Bägli
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

2.  Safety and short-term efficacy of mirabegron in children with valve bladder: a pilot study.

Authors:  Ramesh Babu; Thiyagarajan Chittibabu; Sugandh Chadha
Journal:  Pediatr Surg Int       Date:  2021-12-02       Impact factor: 1.827

3.  Bladder height width ratio on voiding cystourethrogram as a predictor of future valve bladder in children with posterior urethral valve.

Authors:  Ramesh Babu; Venkata Sai
Journal:  Pediatr Surg Int       Date:  2022-04-13       Impact factor: 1.827

4.  Posterior urethral valves: incidence and progress of vesicoureteric reflux after primary fulguration.

Authors:  K Priti; K L N Rao; P Menon; N Singh; B R Mittal; A Bhattacharya; S K Mitra
Journal:  Pediatr Surg Int       Date:  2004-01-24       Impact factor: 1.827

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.